Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Renovaro Issues Shareholder Letter and Provides Corporate Update LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics...
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in...
Renovaro Announces Strategic Restructuring and Leadership Transition Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full...
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics Strategic partnership aims to further develop Cube’s award-winning...
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection Assessment by specialist AI team from “PersonalAIze”...
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress AMSTERDAM, Sept. 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) RenovaroCube...
RenovaroCube Announces Strategic Offering of Up to 20% Ownership AMSTERDAM, Sept. 11, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) The Board of Renovaro, Inc (RENB) intends to seek strategic...
Renovaro, Inc. Announces $10 million in Equity Committed LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in...
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) and the...
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.251 | 53.6324786325 | 0.468 | 0.468 | 0.468 | 1550 | 0.468 | DE |
| 4 | 0.187 | 35.1503759398 | 0.532 | 0.532 | 0.468 | 860 | 0.47432558 | DE |
| 12 | 0.187 | 35.1503759398 | 0.532 | 0.901 | 0.3995 | 2897 | 0.59071719 | DE |
| 26 | -0.695 | -49.1513437058 | 1.414 | 1.792 | 0.3995 | 3202 | 1.05561359 | DE |
| 52 | -2.281 | -76.0333333333 | 3 | 4.3 | 0.3995 | 1962 | 1.33849569 | DE |
| 156 | -2.341 | -76.5032679739 | 3.06 | 4.88 | 0.3995 | 1789 | 1.79569588 | DE |
| 260 | -2.341 | -76.5032679739 | 3.06 | 4.88 | 0.3995 | 1789 | 1.79569588 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
